Menu
Back to Journals » OncoTargets and Therapy » Volume 13
Original Research
MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,098 | Dovepress* | 4,692+ | 757 | 5,449 | |
| PubMed Central* | 406 | 108 | 514 | ||
| Totals | 5,098 | 865 | 5,963 | ||
| *Since 17 August 2020 | |||||
View citations on PubMed Central and Google Scholar